Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol

NCT01120964 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Septal Defect
Ventricular Septal Defect
Atrioventricular Septal Defect

Interventions

DRUG: Intravenous L-Citrulline
DRUG: Placebo of Intravenous L-Citrulline

Sponsor

Asklepion Pharmaceuticals, LLC